NCT04341519

Brief Summary

Coronavirus disease 2019 (COVID-19) is an infectious disease responsible for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is highly contagious requiring restrictive and stressful measures for patients, family members and ICU healthcare providers. To avoid contagion, patient isolation has become the rule. For patients, these measures add stress to the ICU environment and deprive them of unrestricted family visits. Family members are not only left with fear but also many unanswered questions. In end-of-life situations, many family members are unable to say good-bye and unable to provide support to their loved-one throughout the process. The impact of exclusion or limited inclusion certainly needs to be explored. Moreover, ICU caregivers are having to face new challenges and to work in a unknown situation, juggling with both professional issues such as increased workload, working longer hours and safety issues, and personal issues such as child care and transport as well as family transmission of the virus. The main objective of this study is to demonstrate that the COVID-19 pandemic, as compared to seasonal flu and community acquired pneumonia, significantly increases post-traumatic stress disorder (PTSD) in family members of critically ill patients. PTSD-related symptoms will be assessed in family members using the IES-R (impact of event scale revised) during a telephone interview 90 days after ICU discharge. The IES-R is a 22-item self-report measure that assesses subjective distress caused by traumatic events. It will be compared across the three groups (COVID-19, FLU and CAP).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,464

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 7, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 10, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

October 6, 2020

Status Verified

October 1, 2020

Enrollment Period

8 months

First QC Date

April 7, 2020

Last Update Submit

October 5, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • PTSD Family members sup 22

    Proportion of Family members with IES-R\> 22 PTSD-related symptoms will be assessed in family members using the IES-R (impact of event scale revised) during a telephone interview 90 days after ICU discharge of corresponding patient. It si a scale ranging from 0 to 88. Weiss, DS.; Marmar, CR. The impact of event scale - revised. In: Wilson, JP.; Keane, TM., editors.Assessing psychological trauma and PTSD. New York: Guilford Press; 1997. p. 399-411

    90 days

Secondary Outcomes (11)

  • PTSD Family members

    90 days

  • PTSD Patients

    90 days

  • PTSD healthcare providers

    2 months after official end of the Covid-19 peak

  • HADS Family members

    90 days

  • HADS Patients

    90 days

  • +6 more secondary outcomes

Study Arms (3)

Family members

* Age\>18y * Non-opposition to participate to the telephone interviews * One family member per patient: the family member the most implicated in the patient's care 3 groups of Family members will be enrolled in the study corresponding to patients with COVID-19, patients with seasonal flu and patients with community acquired pneumonia (See below). 1 family member per patient will be recruited.

Behavioral: PTSD

Patients

Patients: * Age\>18y * Admission to the participating ICUs for any cause of acute respiratory failure during the COVID-19 pandemic * Having received invasive or noninvasive mechanical ventilation * Non-opposition to participate to the telephone interviews. 3 groups of patients will be enrolled in the study: patients with COVID-19, patients with seasonal flu and patients with community acquired pneumonia. * COVID group : Patients admitted to the ICU for acute respiratory failure and having a positive 2019-nCOV RT PCR in a respiratory / nasal swab sample (GROUP COVID-19) * Group FLU : patients admitted to the ICU for acute respiratory failure and having a confirmed influenza pneumonia * Group CAP (Community-acquired pneumonia) : patients admitted to the ICU for acute respiratory failure and having a clinically or microbiologically documental community acquired pneumonia with negative COVID-19 and Influenza PCRs.

Behavioral: PTSD

healthcare providers

Two months after the official end of the COVID-19 peak in France, the local investigator will receive a set of 100 questionnaires. He/she will be responsible for proposing survey participation to volunteer healthcare providers. Those who are interested will be given the information letter and the questionnaires in an envelope. Once completed anonymously, they will seal the envelope and give it to the local investigator who will then send us all completed questionnaires by registered post.

Behavioral: Burnout

Interventions

PTSDBEHAVIORAL

family members: post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days Patients: post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days

Family membersPatients
BurnoutBEHAVIORAL

Symptoms of burnout as assessed by the Maslash Burnout Inventory

healthcare providers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Family members, Patients hospitalized in ICU for COVID19 infection. Healthcare providers involved in care of patients hospitalized in ICU for COVID19 infection.

You may qualify if:

  • Patients:
  • Age\>18y
  • Admission to the participating ICUs for any cause of acute respiratory failure during the COVID-19 pandemic
  • Having received invasive or noninvasive mechanical ventilation
  • Non-opposition to participate to the telephone interviews.
  • Family members:
  • Age\>18y
  • Non-opposition to participate to the telephone interviews
  • One family member per patient: the family member the most implicated in the patient's care
  • Healthcare providers:
  • All nurses and physicians (including those in training) in the participating ICUs during the COVID-19 pandemic

You may not qualify if:

  • Patients:
  • Language barrier to be able to respond to the telephone interview
  • Cognitive disorders disabling patients to respond to the telephone interview
  • Person under legal protection (1121-8 of CSP, Public Health Code) Failure to obtain the non-opposition
  • Family members:
  • Language barrier to be able to respond to the telephone interview
  • Person under legal protection (1121-8 of CSP, Public Health Code)
  • Failure to obtain the non-opposition
  • Healthcare providers:
  • Failure to obtain the non-opposition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cochin

Paris, France

RECRUITING

Pitié Salpetrière

Paris, France

RECRUITING

Saint-Louis Hospital

Paris, Île-de-France Region, 75010, France

NOT YET RECRUITING

Related Publications (1)

  • Azoulay E, Resche-Rigon M, Megarbane B, Reuter D, Labbe V, Cariou A, Geri G, Van der Meersch G, Kouatchet A, Guisset O, Bruneel F, Reignier J, Souppart V, Barbier F, Argaud L, Quenot JP, Papazian L, Guidet B, Thiery G, Klouche K, Lesieur O, Demoule A, Guitton C, Capellier G, Mourvillier B, Biard L, Pochard F, Kentish-Barnes N. Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge. JAMA. 2022 Mar 15;327(11):1042-1050. doi: 10.1001/jama.2022.2017.

MeSH Terms

Conditions

Coronavirus InfectionsStress Disorders, Post-Traumatic

Interventions

Maslach Burnout Inventory

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfectionsStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Elie AZOULAY, MD PhD

    APHP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nancy KENTISH-BARNES, PhD

CONTACT

Matthieu RESCHE-RIGON, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2020

First Posted

April 10, 2020

Study Start

April 6, 2020

Primary Completion

November 30, 2020

Study Completion

December 31, 2021

Last Updated

October 6, 2020

Record last verified: 2020-10

Locations